大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/22 | 6,614 | 6,677 | 6,551 | 6,634 | +3 | ±0% | 1,050,400 |
| 2025/05/21 | 6,620 | 6,680 | 6,595 | 6,631 | +36 | +0.5% | 842,600 |
| 2025/05/20 | 6,664 | 6,664 | 6,541 | 6,595 | -45 | -0.7% | 1,179,600 |
| 2025/05/19 | 6,646 | 6,704 | 6,573 | 6,640 | +28 | +0.4% | 864,300 |
| 2025/05/16 | 6,636 | 6,686 | 6,573 | 6,612 | +66 | +1% | 904,700 |
| 2025/05/15 | 6,520 | 6,580 | 6,465 | 6,546 | -134 | -2% | 1,271,200 |
| 2025/05/14 | 6,700 | 6,726 | 6,625 | 6,680 | -165 | -2.4% | 1,263,500 |
| 2025/05/13 | 6,867 | 6,930 | 6,734 | 6,845 | +150 | +2.2% | 1,786,400 |
| 2025/05/12 | 6,962 | 6,984 | 6,687 | 6,695 | -380 | -5.4% | 1,984,400 |
| 2025/05/09 | 7,261 | 7,264 | 7,075 | 7,075 | -161 | -2.2% | 1,951,000 |
| 2025/05/08 | 7,414 | 7,446 | 7,235 | 7,236 | -178 | -2.4% | 1,073,400 |
| 2025/05/07 | 7,600 | 7,600 | 7,212 | 7,414 | -283 | -3.7% | 2,452,400 |
| 2025/05/02 | 7,415 | 7,757 | 7,382 | 7,697 | +382 | +5.2% | 2,516,000 |
| 2025/05/01 | 7,058 | 7,374 | 7,009 | 7,315 | +358 | +5.1% | 1,917,200 |
| 2025/04/30 | 6,747 | 7,058 | 6,680 | 6,957 | +174 | +2.6% | 2,792,000 |
| 2025/04/28 | 6,830 | 6,832 | 6,719 | 6,783 | +31 | +0.5% | 1,223,100 |
| 2025/04/25 | 6,774 | 6,880 | 6,663 | 6,752 | +45 | +0.7% | 1,411,100 |
| 2025/04/24 | 6,785 | 6,789 | 6,627 | 6,707 | +4 | +0.1% | 1,067,200 |
| 2025/04/23 | 6,750 | 6,750 | 6,633 | 6,703 | +71 | +1.1% | 1,046,300 |
| 2025/04/22 | 6,544 | 6,638 | 6,510 | 6,632 | +22 | +0.3% | 778,200 |
| 2025/04/21 | 6,782 | 6,795 | 6,610 | 6,610 | -220 | -3.2% | 765,300 |
| 2025/04/18 | 6,783 | 6,839 | 6,721 | 6,830 | +30 | +0.4% | 687,200 |
| 2025/04/17 | 6,710 | 6,835 | 6,702 | 6,800 | +28 | +0.4% | 676,000 |
| 2025/04/16 | 6,767 | 6,847 | 6,695 | 6,772 | -55 | -0.8% | 1,311,000 |
| 2025/04/15 | 6,903 | 6,950 | 6,807 | 6,827 | +24 | +0.4% | 743,100 |
| 2025/04/14 | 6,800 | 6,979 | 6,768 | 6,803 | +79 | +1.2% | 1,063,000 |
| 2025/04/11 | 6,799 | 6,881 | 6,688 | 6,724 | -475 | -6.6% | 2,116,300 |
| 2025/04/10 | 7,325 | 7,341 | 7,077 | 7,199 | +274 | +4% | 1,988,800 |
| 2025/04/09 | 7,204 | 7,218 | 6,801 | 6,925 | -365 | -5% | 1,810,300 |
| 2025/04/08 | 7,316 | 7,362 | 7,158 | 7,290 | +124 | +1.7% | 1,255,800 |
| 2025/04/07 | 7,154 | 7,362 | 7,017 | 7,166 | -438 | -5.8% | 1,385,900 |
| 2025/04/04 | 7,517 | 7,858 | 7,506 | 7,604 | +4 | +0.1% | 1,743,600 |
| 2025/04/03 | 7,400 | 7,646 | 7,367 | 7,600 | +7 | +0.1% | 1,524,800 |
| 2025/04/02 | 7,850 | 7,850 | 7,578 | 7,593 | -324 | -4.1% | 1,217,300 |
| 2025/04/01 | 7,892 | 7,949 | 7,831 | 7,917 | +164 | +2.1% | 1,096,700 |
| 2025/03/31 | 7,924 | 7,952 | 7,685 | 7,753 | -321 | -4% | 1,524,800 |
| 2025/03/28 | 8,036 | 8,082 | 7,966 | 8,074 | +93 | +1.2% | 1,249,000 |
| 2025/03/27 | 8,008 | 8,080 | 7,910 | 7,981 | -72 | -0.9% | 1,119,200 |
| 2025/03/26 | 8,134 | 8,144 | 7,985 | 8,053 | -30 | -0.4% | 1,183,300 |
| 2025/03/25 | 8,190 | 8,192 | 8,027 | 8,083 | -25 | -0.3% | 878,400 |
| 2025/03/24 | 8,130 | 8,140 | 8,045 | 8,108 | -68 | -0.8% | 860,300 |
| 2025/03/21 | 7,956 | 8,176 | 7,912 | 8,176 | +187 | +2.3% | 2,298,000 |
| 2025/03/19 | 7,995 | 8,135 | 7,906 | 7,989 | +137 | +1.7% | 1,412,300 |
| 2025/03/18 | 7,798 | 7,911 | 7,713 | 7,852 | +140 | +1.8% | 993,000 |
| 2025/03/17 | 7,620 | 7,792 | 7,620 | 7,712 | +94 | +1.2% | 781,400 |
| 2025/03/14 | 7,589 | 7,710 | 7,514 | 7,618 | -40 | -0.5% | 1,372,500 |
| 2025/03/13 | 7,629 | 7,709 | 7,585 | 7,658 | +80 | +1.1% | 1,141,500 |
| 2025/03/12 | 7,440 | 7,625 | 7,379 | 7,578 | +68 | +0.9% | 1,181,300 |
| 2025/03/11 | 7,366 | 7,550 | 7,309 | 7,510 | +119 | +1.6% | 1,123,200 |
| 2025/03/10 | 7,507 | 7,520 | 7,343 | 7,391 | -35 | -0.5% | 911,500 |
51～
100
件表示中 / 3580件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 745,800円 | +2.2% | +28.0% | 1.88% | 11.94倍 | 1.45倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 367,800円 | +6.0% | +4.0% | 2.12% | 22.84倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 421,700円 | -1.1% | +75.3% | 4.74% | 29.21倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 157,600円 | +0.9% | +380.2% | 4.95% | 21.71倍 | 1.87倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,700円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
